INTERNATIONAL BIOTECHNOLOGY TRUST PLC - MIRATI THERAPEUTICS INC ownership

MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 228 filers reported holding MIRATI THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.6%.

Quarter-by-quarter ownership
INTERNATIONAL BIOTECHNOLOGY TRUST PLC ownership history of MIRATI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$9,404,640
+0.1%
216,000
-16.9%
3.17%
+10.8%
Q2 2023$9,393,800
+3.5%
260,000
+6.6%
2.86%
+13.0%
Q1 2023$9,071,920
-17.9%
244,0000.0%2.53%
-25.9%
Q4 2022$11,055,640
+16.4%
244,000
+79.4%
3.42%
+12.1%
Q3 2022$9,498,000
-93.0%
136,000
+1389.4%
3.05%
+114.7%
Q2 2022$136,000,000
+9805.3%
9,131
-95.2%
1.42%
+357.7%
Q1 2022$1,373,000
-92.6%
188,500
+49.0%
0.31%
-92.5%
Q4 2021$18,549,000
+6.5%
126,500
+28.4%
4.13%
-1.6%
Q3 2021$17,419,000
+538.1%
98,500
+482.8%
4.20%
+482.7%
Q2 2021$2,730,000
-76.3%
16,900
-74.9%
0.72%
-76.4%
Q1 2021$11,536,000
-22.1%
67,4000.0%3.05%
-24.5%
Q4 2020$14,804,000
+231.8%
67,400
+150.6%
4.04%
+180.8%
Q3 2020$4,462,000
-11.3%
26,900
-38.7%
1.44%
-13.9%
Q2 2020$5,032,000
+49.1%
43,9000.0%1.67%
+8.8%
Q1 2020$3,374,000
-27.1%
43,900
+22.3%
1.54%
-7.8%
Q4 2019$4,630,000
+445.3%
35,900
+229.4%
1.67%
+325.5%
Q3 2019$849,000
-24.4%
10,9000.0%0.39%
-5.8%
Q2 2019$1,123,000
-29.4%
10,900
-49.8%
0.42%
-29.1%
Q1 2019$1,590,00021,7000.59%
Other shareholders
MIRATI THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Aviva Holdings Ltd. 2,881,702$14,985,0006.99%
Avoro Capital Advisors LLC 2,383,201$12,393,0001.58%
Broadfin Capital, LLC 2,090,801$10,872,0001.32%
Boxer Capital, LLC 1,037,994$5,398,0001.18%
Ghost Tree Capital, LLC 172,184$895,0000.17%
Baker Brothers Advisors 2,269,198$11,800,0000.10%
Hillhouse Capital Management 725,000$3,770,0000.07%
SABBY MANAGEMENT, LLC 249,735$1,299,0000.07%
Rhenman & Partners Asset Management AB 50,000$260,0000.04%
Trexquant Investment LP 42,879$223,0000.03%
View complete list of MIRATI THERAPEUTICS INC shareholders